Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Thumbnail

PBMs blame insurers for high drug prices

Pharmacy benefit managers (PBMs)—the industry middlemen that negotiate drug prices—are passing on nearly all their savings to insurance providers, according to Terry Wilcox, co-founder and executive director of advocacy organization Patients Rising. His op-ed for The Hill placed the blame of high costs squarely on insurers.

Thumbnail

Another industry group speaks out against CVS-Aetna deal

The Association of American Physicians and Surgeons (AAPS) wrote a letter to Attorney General Jeff Sessions in opposition to the $69 billion merger of CVS Health and Aetna.

Thumbnail

68 cataract patients left nearly blind after receiving injections of knockoff drug

Nearly 70 cataract patients are partially blind after receiving a knockoff version of a drug, according to a report by BuzzFeed News.

Thumbnail

Top 10 healthcare challenges for 2019

Looking into 2019, healthcare executives see a lot of the same top challenges as they did in 2018, but digital health and patient-centered care are rising concerns.

Thumbnail

More industry groups oppose changes to ACO program

Nine industry groups have joined in opposition to CMS’s proposed changes to the Medicare Shared Savings Program.

Thumbnail

Alzheimer’s and dementia cases will double by 2060

As the American population ages, the number of cases of Alzheimer’s disease and other forms of dementia is set to explode, according to the CDC.

Thumbnail

CVS in ‘home stretch’ of antitrust process to acquire Aetna for $69B

CVS Health is in the “home stretch” of the regulatory process with the Justice Department and state regulators for its $69 billion merger with Aetna, according to CEO Larry Merlo.

Thumbnail

Andy Slavitt’s Town Hall Ventures raises $115M

Town Hall Ventures, the investment firm started by former CMS administrator Andy Slavitt, has raised $115 million.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup